<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">IJO</journal-id><journal-id journal-id-type="publisher-id">Indian J Ophthalmol</journal-id><journal-title-group><journal-title>Indian Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0301-4738</issn><issn pub-type="epub">1998-3689</issn><publisher><publisher-name>Wolters Kluwer - Medknow</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38648460</article-id><article-id pub-id-type="pmc">PMC467011</article-id>
<article-id pub-id-type="publisher-id">IJO-72-509</article-id><article-id pub-id-type="doi">10.4103/IJO.IJO_3141_23</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Differences of ocular oscillations and neuro-retinal structures in patients with nystagmus caused by <italic toggle="yes">GPR143</italic> and <italic toggle="yes">FRMD7</italic> gene variants</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Lijuan</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Biru</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Ningdong</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Ophthalmology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China</aff><aff id="aff2"><label>2</label>Department of Ophthalmology, Shanghai General Hospital, Shanghai, China</aff><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Dr. Ningdong Li, Shanghai General Hospital, Shanghai - 200940, China. E-mail: <email xlink:href="lnd30@163.com">lnd30@163.com</email></corresp></author-notes><!--Fake ppub date generated by PMC from publisher
					pub-date/@pub-type='epub-ppub'--><pub-date pub-type="ppub"><month>5</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>20</day><month>4</month><year>2024</year></pub-date><volume>72</volume><issue>Suppl 3</issue><fpage>S509</fpage><lpage>S513</lpage><history><date date-type="received"><day>30</day><month>11</month><year>2023</year></date><date date-type="rev-recd"><day>07</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>19</day><month>3</month><year>2024</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2024 Indian Journal of Ophthalmology</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Purpose:</title><p>Mutations of G protein-coupled receptor 143 (GPR143) and FERM domain containing 7 (FRMD7) may result in congenital nystagmus (CN) in the first 6 months of life. We aimed to compare the differences in ocular oscillations between patients with these two gene mutations as well as the functional and structural changes in their retinas and visual pathways.</p></sec><sec id="st2"><title>Methods:</title><p>Medical records were retrospectively reviewed to identify patients of congenital nystagmus with confirmed mutations in either <italic toggle="yes">GPR143</italic> or <italic toggle="yes">FMRD7</italic> genes from January 2018 to May 2023. The parameters of the ocular oscillations were recorded using Eyelink 1000 Plus. The retinal structure and function were evaluated using optical coherence tomography and multi-focal electroretinography (mERG). The visual pathway and optical nerve projection were evaluated using visual evoked potentials. The next-generation sequencing technique was used to identify the pathogenic variations in the disease-causing genes for CN.</p></sec><sec id="st3"><title>Results:</title><p>Twenty nystagmus patients of GPR143 and 21 patients of FMRD7 who had been confirmed by molecular testing between January 2018 and May 2023 were included. Foveal hypoplasia was detected only in patients with the <italic toggle="yes">GPR143</italic> pathogenic variant. mERG examination showed a flat response topography in the GPR143 group compared to the FRMD7 group. VEP showed that bilateral amplitude inconsistency was detected only in the patients with <italic toggle="yes">GPR143</italic> gene mutation. The amplitude and frequency of the ocular oscillations were not found to differ between patients with two different genetic mutations.</p></sec><sec id="st4"><title>Conclusions:</title><p>Although the etiology and molecular mechanisms are completely different between CN patients, they may have similar ocular oscillations. A careful clinical examination and electrophysiological test will be helpful in making a differential diagnosis. Our novel identified variants will further expand the spectrum of the <italic toggle="yes">GPR143</italic> and <italic toggle="yes">FRMD7</italic> variants.</p></sec></abstract><kwd-group><kwd>FRMD7</kwd><kwd>gene</kwd><kwd>GPR143</kwd><kwd>nystagmus</kwd></kwd-group></article-meta></front><body><p>Congenital nystagmus (CN) refers to a group of ocular motor disorders presented in the early 6 months of life and characterized by rhythmic to-and-for ocular oscillation.[<xref rid="R1" ref-type="bibr">1</xref>] It can be classified into the &#x0201c;motor defect&#x0201d; and the &#x0201c;sensory defect&#x0201d; types of nystagmus. The motor defect nystagmus, also known as congenital idiopathic nystagmus, does not have disorders in the eyes and visual pathways, whereas the sensory defect nystagmus usually does.[<xref rid="R2" ref-type="bibr">2</xref>]</p><p>FERM domain containing 7 (<italic toggle="yes">FRMD7</italic>) and G protein-coupled receptor 143 (<italic toggle="yes">GPR143</italic>) are two genes identified from the locus of NYS1 and NYS6 on the X-chromosome, respectively. Mutations in these two genes may cause CN.[<xref rid="R3" ref-type="bibr">3</xref>] However, with the exception of nystagmus, clinical features differ between patients with the GPR143 mutation and those with the <italic toggle="yes">FRMD7</italic> mutation.[<xref rid="R4" ref-type="bibr">4</xref>] Patients with the <italic toggle="yes">GPR143</italic> mutation may have foveal hypoplasia, hypo-pigmentation in the retina, and chiasmal misrouting.[<xref rid="R5" ref-type="bibr">5</xref><xref rid="R6" ref-type="bibr">6</xref>] Due to structural changes in the eye and visual pathways, nystagmus caused by the <italic toggle="yes">GPR143</italic> mutation should be considered a sensory defect type.</p><p>Here, we aim to investigate the nature of nystagmus caused by mutations in the <italic toggle="yes">FRMD7</italic> and <italic toggle="yes">GPR143</italic> genes in order to obtain a diagnostic basis for distinguishing between the two causes of nystagmus.</p><sec sec-type="methods" id="sec1-1"><title>Methods</title><sec id="sec2-1"><title>Patients</title><p>Medical records were retrospectively reviewed to identify patients of CN with confirmed mutations in either <italic toggle="yes">GPR143</italic> or <italic toggle="yes">FMRD7</italic> genes from January 2018 to May 2023. A total of 20 patients with <italic toggle="yes">GPR143</italic> and 21 with <italic toggle="yes">FRMD7</italic> gene variants were identified. All patients underwent careful examinations including the best corrected visual acuity, the anterior segment of the eyeball, and fundus. Patients were classified into two groups, the GPR143 and FRMD7 groups, based on the molecular diagnosis. Fundus photography was taken using Canon CX-1 (Canon company, Japan). Optical coherence tomography (OCT) and OCT angiography (OCTA) (Heidelberg Engineering, Germany) were used to evaluate the retinal structure. Foveal hypoplasia (FH) was classified into 1&#x02013;4 grades according to the Leicester Grading System. Visual evoked potentials (VEPs) and multi-focal electroretinography (mERG) were recorded using the RETI-scan 21 system (Roland company, Germany). Ocular oscillations ware recorded using Eyelink 1000 Plus.[<xref rid="R7" ref-type="bibr">7</xref>] Ocular alignment and ocular movement were assessed at nine cardinal diagnostic positions. This study was approved by the Ethics Committee of the Shanghai General Hospital and adhered to the principles of the Declaration of Helsinki. Written informed consent was obtained from the patients or the parents of the affected children.</p></sec><sec id="sec2-2"><title>Molecular diagnosis</title><p>Molecular diagnostics were performed using the method described in our previous publications.[<xref rid="R7" ref-type="bibr">7</xref>] Briefly, the next-generation-sequencing-based comprehensive gene panel technique was performed to identify the pathogenic variations in the nystagmus-associated genes by a commercial service (MyGenostics Inc, Beijing, China). Variants were analyzed using the Genome Analysis Toolkit program and searched in the dbSNP151, EXAC, gnomAD 2.1, ClinVar, and HGMD2021 databases. Pathogenicity prediction scores were obtained for missense variants using SIFT, PolyPhen-2, MutationTaster, and CADD and further confirmed by modeling the three-dimensional structure of protein using the PyMOL program. Multiple sequence alignments were performed using the ClustalW algorithm in the DNAStar software package (DNAStar Inc., Madison, WI, United States). Pathogenicity assessment was based on the American College of Medical Genetics/AMP guidelines. Mutations are named following the nomenclature recommended by the Human Genomic Variation Society.</p></sec><sec id="sec2-3"><title>Statistical analysis</title><p>Statistical analysis was performed to compare the difference of oscillations between the patients with <italic toggle="yes">GPR143</italic> and <italic toggle="yes">FRMD7</italic> variants using the independent <italic toggle="yes">t</italic>-test, with a <italic toggle="yes">P</italic> value of &#x0003c;0.05 being considered statistically significant. All statistical analyses were carried out using the SPSS 24.0 software (IBM Corporation, Armonk, NY, USA).</p></sec></sec><sec sec-type="results" id="sec1-2"><title>Results</title><sec id="sec2-4"><title>Molecular genetic testing</title><p>Twenty patients were detected with the <italic toggle="yes">GPR143</italic> variants, including seven novel variants of c.12_36del (p. Leu6Glyfs*10), c.98G&#x0003e;A (p. Cys33Tyr), c.693C&#x0003e;A (p. Tyr231*), c.733del (p. R245Dfs*9), c.768_769delTT (p. Cys256Trpfs *8), c.904dupC (p. Gln302Profs*37), and c.884T&#x0003e;G (p. Met295Arg) [<xref rid="IJO.IJO_3141_23-F1" ref-type="fig">Fig. 1</xref> and <xref rid="IJO.IJO_3141_23-T1" ref-type="table">Table 1</xref>] and 13 previously reported pathogenic variants [<xref rid="IJO.IJO_3141_23-ST1" ref-type="table">Table S1</xref>]. Twenty-one patients were detected with the <italic toggle="yes">FRMD7</italic> variants, including a novel variant of c.1648C&#x0003e;T (p. Leu550Phe) and 20 previously reported variants [<xref rid="IJO.IJO_3141_23-ST2" ref-type="table">Table S2</xref>].</p><fig position="float" id="IJO.IJO_3141_23-F1"><label>Figure 1</label><caption><p>Chromas of the sequencing. Eight novel pathogenic variations in <italic toggle="yes">GPR143</italic> and <italic toggle="yes">FRMD7</italic>. (a-g). Novel variants in <italic toggle="yes">GPR143</italic> gene, (h) A novel variant in <italic toggle="yes">FRMD7</italic> gene</p></caption><graphic xlink:href="IJO-72-509-g001" position="float"/></fig><table-wrap position="float" id="IJO.IJO_3141_23-ST1"><label>Table S1</label><caption><p>Summary of detected pathogenic variations of <italic toggle="yes">GPR143</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">No.</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">cDNA</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Amino Acid Change</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Location</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">ACMG</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CADD</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">SIFT</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Poly Phen-2</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Splice AI</th><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Type of Mutation</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.14G&#x0003e;C</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Arg5Pro</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 21541274</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.12_36del</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Leu6Glyfs*9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.98G&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Cys33Tyr</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.162_198del</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Ala55Argfs*19</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 18523664</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.180dupC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Ala61Argfs*40</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 11214907</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.208_218del</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> p.Ile70Cysfs*27</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 31574285</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.241G&#x0003e;C</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Gly81Arg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 29345414</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.251G&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Gly84Asp</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon2</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">DS_AL=0.23</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 8634705</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.333G&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.W111*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon2</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 21541274</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.659-2 A&#x0003e;C</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Intron5</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">DS_AL=0.23</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Splicing</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 31574285</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.693C&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Tyr231*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon6</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.733C&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p. Arg245*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon6</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 9529334</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.733del</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.R245Dfs*9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon7</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.768_769delTT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Cys256Trpfs *8</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon7</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.817C&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Gln273*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon7</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 34838614</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.876G&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Trp292*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon7</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 11214907</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.884T&#x0003e;G</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Met295Arg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon7</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.885+1G&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Intron7</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">DS_DL=0</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Splicing</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 34346269</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> c.904dupC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Gln302Profs*37</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon8</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.982C&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Gln328*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon8</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 28234808</td></tr></tbody></table><table-wrap-foot><fn id="TF-F1"><p>D - Disease causing; P - Probably damaging; LP - Likely pathogenic. NM_000273</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="IJO.IJO_3141_23-ST2"><label>Table S2</label><caption><p>Summary of detected pathogenic variations of <italic toggle="yes">FRMD7</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">No.</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">cDNA</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Amino Acid Change</th><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Location</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">ACMG</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CADD</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">SIFT</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">PolyPhen-2</th><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Splice AI</th><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Type of Mutation</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.57+2T&#x0003e;C</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Intron 1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">23.4</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">DL (0.92)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Splicing</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.58-3T&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Intron 1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AL (0.78)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Splicing</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.170T&#x0003e;G</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Leu57Arg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Uncertain</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">25.3</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.999</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.206-2T&#x0003e;G</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Intron 4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">24.1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG (1.00) AL (0.75)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Splicing</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.253G&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Asp85Tyr</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Uncertain</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">29.2</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.992</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.284G&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Arg95Met</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">28.6</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.987</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 28623544</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.367T&#x0003e;C</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Ser123Pro</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.997</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.498-2A&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Intron 6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">25.9</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG (0.95) AL (0.97)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Splicing</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.580G&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Ala194Thr</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Uncertain</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.004</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.998</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 32446246</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.586G&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Asp196Tyr</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.999</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.623A&#x0003e;G</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.His208Arg</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">24.7</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.994</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 21365021</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.773T&#x0003e;C</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Met258Tyr</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">26.2</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.974</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.781C&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Arg261*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.849G&#x0003e;C</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.E283Asp</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Uncertain</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">26.2</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.017</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.986C&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Pro329Gln</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 11</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">23.9</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">23.9</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.037</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 23733424</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.1003C&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Arg335*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 11</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 17013395</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.1074T&#x0003e;G</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Tyr358*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.1523G&#x0003e;A</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Trp508*</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.1648C&#x0003e;T</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Leu550Phe</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon 12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.1918delA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Ser640fs</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">LP</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Deletion</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">PMID: 35705619</td></tr></tbody></table><table-wrap-foot><fn id="TF-F2"><p>D - Disease causing; P - Probably damaging; LP - Likely pathogenic</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="IJO.IJO_3141_23-T1"><label>Table 1</label><caption><p>Summary of detected pathogenic variations of <italic toggle="yes">GPR143</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">No.</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">cDNA</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Amino Acid Change</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Location</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">ACMG</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CADD</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">SIFT</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">PolyPhen-2</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Type of Mutation</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.12_36del</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Leu6Glyfs*10</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.98G&#x0003e;A</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Cys33Tyr</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.693C&#x0003e;A</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Tyr231*</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon6</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Nonsense</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.733del</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Arg245Dfs*9</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon7</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.768_769delTT</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Cys256Trpfs *8</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon7</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.884T&#x0003e;G</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Met295Arg</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon7</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">D</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Missense</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">c.904dupC</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p.Gln302Profs*37</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Exon8</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">LP</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Frameshift</td></tr></tbody></table><table-wrap-foot><fn id="TF-F3"><p>D - Disease causing; P - Pathogenic; LP - Likely pathogenic; NM_000273</p></fn></table-wrap-foot></table-wrap><p>All novel missense variants identified in this study were predicted to be deleterious to the function and structure of the proteins and further conformed in the model of the 3-D structures [<xref rid="IJO.IJO_3141_23-F2" ref-type="fig">Fig. 2</xref>]. The model showed that the novel missense mutation of c.98G&#x0003e;A (p.Cys33Tyr) in <italic toggle="yes">GPR143</italic> resulted in a wild-type amino acid of cysteine being replaced by Tyrosine at codon 33 [<xref rid="IJO.IJO_3141_23-F2" ref-type="fig">Fig. 2</xref>a], and the novel missense mutation of c.884T&#x0003e;G (p.Met295Arg) resulted in a wild-type non-polar amino acid of methionine being replaced by arginine with positive polarity at codon 295 [<xref rid="IJO.IJO_3141_23-F2" ref-type="fig">Fig. 2</xref>b], which would damage the stability of the protein structure and function. The calculated scores for all variants using the programs of SIFT, Polyphen2, CADD, and Splice AI, as well as the ACMG classification, are listed in <xref rid="IJO.IJO_3141_23-T1" ref-type="table">Table 1</xref>.</p><fig position="float" id="IJO.IJO_3141_23-F2"><label>Figure 2</label><caption><p>Three-dimensional model construction for novel missense variations of c.98G&#x0003e;A (p. Cys33Tyr) (a) and c.884T&#x0003e;G (p. Met295Arg) (b) in <italic toggle="yes">GPR143</italic></p></caption><graphic xlink:href="IJO-72-509-g002" position="float"/></fig></sec><sec id="sec2-5"><title>Clinical features</title><p>All patients presented with reduced visual acuity and horizontal jerk nystagmus. Five of the 20 patients with the <italic toggle="yes">GPR143</italic> variant and seven of the 21 patients with the <italic toggle="yes">FRMD7</italic> variant had a face turn when they fixated the target at distance. Strabismus was present in six patients with the <italic toggle="yes">GPR143</italic> variant and in five patients with the <italic toggle="yes">FRMD7</italic> variant. Patients with the <italic toggle="yes">FRMD7</italic> variant had normal foveal depression without hypo-pigmentation of iris and fundus [<xref rid="IJO.IJO_3141_23-F3" ref-type="fig">Fig. 3</xref>a-c]. Besides the nystagmus, patients with the <italic toggle="yes">GPR143</italic> variant had retinal hypo-pigmentation, iris hypo-pigmentation in the ciliary region, and foveal hypoplasia of the grade 4 on OCT examination [<xref rid="IJO.IJO_3141_23-F3" ref-type="fig">Fig. 3</xref>e-g]. OCTA imaging showed that there was a normal foveal avascular zone (FAZ) in the patient with the <italic toggle="yes">FRMD7</italic> variant [<xref rid="IJO.IJO_3141_23-F3" ref-type="fig">Fig. 3</xref>d], and there was absence of FAZ in the patient with the <italic toggle="yes">GPR143</italic> variant [<xref rid="IJO.IJO_3141_23-F3" ref-type="fig">Fig. 3</xref>h].</p><fig position="float" id="IJO.IJO_3141_23-F3"><label>Figure 3</label><caption><p>Clinical features in patients with the <italic toggle="yes">FRMD7</italic> variant (a - d) and <italic toggle="yes">GPR143</italic> variant (e - h)</p></caption><graphic xlink:href="IJO-72-509-g003" position="float"/></fig></sec><sec id="sec2-6"><title>Electrophysiological examination</title><p>Asymmetrical hemispheric VEPs were recorded in the patients with the <italic toggle="yes">GPR143</italic> variant, showing asymmetrical responses to the stimulation from each eye and with the greatest response from the contralateral side, but were not in the patients with the <italic toggle="yes">FRMD7</italic> variant [<xref rid="IJO.IJO_3141_23-F4" ref-type="fig">Fig. 4</xref>]. Multi-focal ERG recordings depicted a relative flat topography in the macular region in the patients with the <italic toggle="yes">GPR143</italic> variant compared to the patients with the <italic toggle="yes">FRMD7</italic> variant [<xref rid="IJO.IJO_3141_23-F5" ref-type="fig">Fig. 5</xref>].</p><fig position="float" id="IJO.IJO_3141_23-F4"><label>Figure 4</label><caption><p>The VEPs showed normal in patients with <italic toggle="yes">FRMD7</italic> variant (a) and a hemispheric asymmetry in patients with <italic toggle="yes">GPR143</italic> variant (b)</p></caption><graphic xlink:href="IJO-72-509-g004" position="float"/></fig><fig position="float" id="IJO.IJO_3141_23-F5"><label>Figure 5</label><caption><p>Central retinal function assessed by the mERG showed normal in <italic toggle="yes">FRMD7</italic>-group (a,b), and a flat response topography with depressed macular function in <italic toggle="yes">GPR143</italic>-group (c,d)</p></caption><graphic xlink:href="IJO-72-509-g005" position="float"/></fig></sec><sec id="sec2-7"><title>Comparisons of BCVA and nystagmus</title><p>The mean of BCVA was 0.39 &#x000b1; 0.12 in the patients with the <italic toggle="yes">GPR143</italic> variant and 0.53 &#x000b1; 0.14 in the patients with the <italic toggle="yes">FRMD7</italic> variant. Compared with the patients with the <italic toggle="yes">FRMD7</italic> variant, the patients with the <italic toggle="yes">GPR143</italic> have a more reduced visual acuity (<italic toggle="yes">P</italic> = 0.043, <italic toggle="yes">P</italic> &#x0003c; 0.05).</p><p>The waveforms of nystagmus were various, including jerky, double jerky waveforms, and jerky with extended foveation waveforms, pendular, pendular with floating saccades, and were not specific to patients with any of the genetic variants.</p><p>Eye movement recordings showed that the amplitude of oscillation was on the average of 3.50&#x000b0; &#x000b1;1.93&#x000b0; in the patients with the <italic toggle="yes">GPR143</italic> variant and 3.24&#x000b0; &#x000b1;2.53&#x000b0; in the patients with the <italic toggle="yes">FRMD7</italic> variant at the primary gaze position. There were no significant differences between two groups in the amplitude (<italic toggle="yes">P</italic> = 0.846, <italic toggle="yes">P</italic> &#x0003e; 0.05). The frequency of oscillation was a mean of 3.01 Hz &#x000b1; 1.41 Hz in the patients with the <italic toggle="yes">GPR143</italic> variant and 2.87 Hz &#x000b1; 1.70 Hz in the patients with the <italic toggle="yes">FRMD7</italic> variant at the primary gaze position. There were no significant differences between these two groups in frequency (<italic toggle="yes">P</italic> = 0.532, <italic toggle="yes">P</italic> &#x0003e; 0.05).</p></sec></sec><sec sec-type="discussion" id="sec1-3"><title>Discussion</title><p>The stability of fixation relies on a healthy visual system, a vestibular-ocular reflex system, and the integration of all input and output information by the brain, where the visual system plays an important role in processing afferent visual information to the brain, identifying image drift on the retina, programming corrective saccadic eye movements, and providing feedback to the brain so that the brain may optimize the efferent information from the ocular motor control system.[<xref rid="R8" ref-type="bibr">8</xref>]</p><p>The protein encoded by the <italic toggle="yes">GPR143</italic> gene plays an important role not only in melanin biogenesis but also in the development of neural tissue. Mutations of <italic toggle="yes">GPR143</italic> can result in the foveal hypoplasia and chiasmal misrouting and cause structural and morphological changes of retina and nerve fiber projections, which would affect the processing of the visual information in the brain, resulting in nystagmus.[<xref rid="R9" ref-type="bibr">9</xref><xref rid="R10" ref-type="bibr">10</xref>] In our patients, all patients with the <italic toggle="yes">GPR143</italic> variant showed foveal hypoplasia on OCT examination and chiasmal misrouting documented in VEP examination. The relatively flat ERG amplitude in the central retina means that the photoreceptor cells in the fovea are not functioning well. In contrast, FRMD7 is expressed in the retina and the midbrain where the center of the ocular movement is located and plays an important role in neurite development as well as in the control of eye movement and gaze stability.[<xref rid="R11" ref-type="bibr">11</xref><xref rid="R12" ref-type="bibr">12</xref>] However, mutations in <italic toggle="yes">FRMD7</italic> do not produce significant structural and morphological changes in the retina and chiasma, as evidenced by OCT examination and VEP and ERG recordings. In theory, because the anatomic basis of nystagmus is different, the characteristics of the oscillations should be different. However, we did not find a difference between the parameters of the oscillations caused by the <italic toggle="yes">GPR143</italic> and <italic toggle="yes">FRMD7</italic> mutations.</p><p>More recently, the mechanism of nystagmus caused by the <italic toggle="yes">FRMD7</italic> mutation has been suggested to be related to signal transmission in the retina. Because the mutant protein cannot interact with the inhibitory transmitter of GABRA2, the inhibitory signal transmitting from the starburst amacrine cells (SACs) to the directional selective ganglion cells (DSGCs) is prevented, resulting asymmetrical optokinetic response.[<xref rid="R13" ref-type="bibr">13</xref>] Although the mechanism by which nystagmus is caused by the <italic toggle="yes">GPR143</italic> mutation is unknown, it is reasonable to postulate that the two types of nystagmus share a common pathway as both are caused by the transmission of signals from the retina to the brain.</p><p>In summary, it is difficult to distinguish the etiology of the two different forms of nystagmus from the amplitude and frequency alone. They may have similar ocular oscillations with or without null zones, regardless of whether they are caused by mutations in the <italic toggle="yes">FRMD7</italic> or <italic toggle="yes">GPR143</italic> genes. Nystagmus with null zones is not unique to patients with motor defect nystagmus. Nystagmus caused by the <italic toggle="yes">GPR143</italic> mutation will also exhibit similar nystagmus features, which is therefore susceptible to being misdiagnosed as idiopathic nystagmus caused by the <italic toggle="yes">FRMD7</italic> mutation. Fundus examination by OCT, electrophysiological examination, and genetic testing are helpful for differential diagnosis.</p><sec sec-type="funding-statement" id="sec2-8"><title>Financial support and sponsorship</title><p>Supported by the National Natural Science Foundation of China (No. 81670883), Natural Science Foundation of Fujian Province (No. 2023J01724), and Fujian Provincial Health Technology Project (No. 2023GGA047).</p></sec><sec sec-type="COI-statement" id="sec2-9"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>We thank all patients and family members for their participation in this study.</p></ack><ref-list><title>References</title><ref id="R1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kates</surname><given-names>MM</given-names></name>
<name><surname>Beal</surname><given-names>CJ</given-names></name></person-group><article-title>Nystagmus</article-title><source>JAMA</source><year>2021</year><volume>325</volume><fpage>798</fpage><pub-id pub-id-type="pmid">33620408</pub-id>
</element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Papageorgiou</surname><given-names>E</given-names></name>
<name><surname>McLean</surname><given-names>RJ</given-names></name>
<name><surname>Gottlob</surname><given-names>I</given-names></name></person-group><article-title>Nystagmus in childhood</article-title><source>Pediatr Neonatol</source><year>2014</year><volume>55</volume><fpage>341</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">25086850</pub-id>
</element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gottlob</surname><given-names>I</given-names></name>
<name><surname>Proudlock</surname><given-names>FA</given-names></name></person-group><article-title>Aetiology of infantile nystagmus</article-title><source>Curr Opin Neurol</source><year>2014</year><volume>27</volume><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">24346039</pub-id>
</element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Choi</surname><given-names>JH</given-names></name>
<name><surname>Jung</surname><given-names>JH</given-names></name>
<name><surname>Oh</surname><given-names>EH</given-names></name>
<name><surname>Shin</surname><given-names>JH</given-names></name>
<name><surname>Kim</surname><given-names>HS</given-names></name>
<name><surname>Seo</surname><given-names>JH</given-names></name>
<etal/></person-group><article-title>Genotype and phenotype spectrum of FRMD7-associated infantile nystagmus syndrome</article-title><source>Invest Ophthalmol Vis Sci</source><year>2018</year><volume>59</volume><fpage>3181</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">30025138</pub-id>
</element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>S</given-names></name>
<name><surname>Kuht</surname><given-names>HJ</given-names></name>
<name><surname>Moon</surname><given-names>EH</given-names></name>
<name><surname>Maconachie</surname><given-names>GDE</given-names></name>
<name><surname>Thomas</surname><given-names>MG</given-names></name></person-group><article-title>Current and emerging treatments for albinism</article-title><source>Surv Ophthalmol</source><year>2021</year><volume>66</volume><fpage>362</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">33129801</pub-id>
</element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>J</given-names></name>
<name><surname>Jia</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Bu</surname><given-names>J</given-names></name></person-group><article-title>A previously unidentified deletion in G protein-coupled receptor 143 causing X-linked congenital nystagmus in a Chinese family</article-title><source>Indian J Ophthalmol</source><year>2016</year><volume>64</volume><fpage>813</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">27958203</pub-id>
</element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>L</given-names></name>
<name><surname>Zhou</surname><given-names>Y</given-names></name>
<name><surname>Chen</surname><given-names>W</given-names></name>
<name><surname>Lin</surname><given-names>P</given-names></name>
<name><surname>Xie</surname><given-names>Y</given-names></name>
<name><surname>He</surname><given-names>K</given-names></name>
<etal/></person-group><article-title>Correlations of FRMD7 gene mutations with ocular oscillations</article-title><source>Sci Rep</source><year>2022</year><volume>15</volume><fpage>9914</fpage></element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kilpel&#x000e4;inen</surname><given-names>M</given-names></name>
<name><surname>Putnam</surname><given-names>NM</given-names></name>
<name><surname>Ratnam</surname><given-names>K</given-names></name>
<name><surname>Roorda</surname><given-names>A</given-names></name></person-group><article-title>The retinal and perceived locus of fixation in the human visual system</article-title><source>J Vis</source><year>2021</year><volume>21</volume><fpage>9</fpage></element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fukuda</surname><given-names>N</given-names></name>
<name><surname>Naito</surname><given-names>S</given-names></name>
<name><surname>Masukawa</surname><given-names>D</given-names></name>
<name><surname>Kaneda</surname><given-names>M</given-names></name>
<name><surname>Miyamoto</surname><given-names>H</given-names></name>
<name><surname>Abe</surname><given-names>T</given-names></name>
<etal/></person-group><article-title>Expression of ocular albinism 1 (OA1), 3, 4- dihydroxy- L-phenylalanine (DOPA) receptor, in both neuronal and non-neuronal organs</article-title><source>Brain Res</source><year>2015</year><volume>1602</volume><fpage>62</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">25601010</pub-id>
</element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Young</surname><given-names>A</given-names></name>
<name><surname>Powelson</surname><given-names>EB</given-names></name>
<name><surname>Whitney</surname><given-names>IE</given-names></name>
<name><surname>Raven</surname><given-names>MA</given-names></name>
<name><surname>Nusinowitz</surname><given-names>S</given-names></name>
<name><surname>Jiang</surname><given-names>M</given-names></name>
<etal/></person-group><article-title>Involvement of OA1, an intracellular GPCR, and G alpha i3, its binding protein, in melanosomal biogenesis and optic pathway formation</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>3245</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">18378571</pub-id>
</element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>MG</given-names></name>
<name><surname>Crosier</surname><given-names>M</given-names></name>
<name><surname>Lindsay</surname><given-names>S</given-names></name>
<name><surname>Kumar</surname><given-names>A</given-names></name>
<name><surname>Araki</surname><given-names>M</given-names></name>
<name><surname>Leroy</surname><given-names>BP</given-names></name>
<etal/></person-group><article-title>Abnormal retinal development associated with FRMD7 mutations</article-title><source>Hum Mol Genet</source><year>2014</year><volume>23</volume><fpage>4086</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">24688117</pub-id>
</element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watkins</surname><given-names>RJ</given-names></name>
<name><surname>Patil</surname><given-names>R</given-names></name>
<name><surname>Goult</surname><given-names>BT</given-names></name>
<name><surname>Thomas</surname><given-names>MG</given-names></name>
<name><surname>Gottlob</surname><given-names>I</given-names></name>
<name><surname>Shackleton</surname><given-names>S</given-names></name></person-group><article-title>A novel interaction between FRMD7 and CASK: Evidence for a causal role in idiopathic infantile nystagmus</article-title><source>Hum Mol Genet</source><year>2013</year><volume>22</volume><fpage>2105</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">23406872</pub-id>
</element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>L</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Yang</surname><given-names>K</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Cui</surname><given-names>X</given-names></name>
<etal/></person-group><article-title>FRMD7 mutations disrupt the interaction with GABRA2 and may result in infantile nystagmus syndrome</article-title><source>Invest Ophthalmol Vis Sci</source><year>2020</year><volume>61</volume><fpage>41</fpage></element-citation></ref></ref-list></back></article>